Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,914 | -62,792 | -33,246 | 30,648 | 55,817 |
| Depreciation Amortization | 3,914 | 2,576 | 1,331 | 5,455 | 3,999 |
| Accounts receivable | -2,088 | -1,972 | -2,279 | -6,819 | -9,356 |
| Accounts payable and accrued liabilities | 1,355 | -4,628 | -1,349 | -343 | 431 |
| Other Working Capital | 193 | -2,399 | -1,048 | -16,378 | -18,396 |
| Other Operating Activity | 7,182 | 10,922 | 5,965 | 13,888 | 13,863 |
| Operating Cash Flow | $-82,358 | $-58,293 | $-30,626 | $26,451 | $46,358 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 154,365 | 100,572 | 59,613 | -141,475 | -159,111 |
| PPE Investments | -4,183 | -2,344 | -1,107 | -2,628 | -1,832 |
| Investing Cash Flow | $150,182 | $98,228 | $58,506 | $-144,103 | $-160,943 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,672 | 3,672 | 3,672 | N/A | 0 |
| Debt Repayment | -2,172 | -2,172 | -2,172 | N/A | 0 |
| Common Stock Issued | 1,297 | 845 | 183 | 115,367 | 114,707 |
| Financing Cash Flow | $2,797 | $2,345 | $1,683 | $115,367 | $114,707 |
| Exchange Rate Effect | -24 | 3 | -4 | N/A | 0 |
| Beginning Cash Position | 43,506 | 43,506 | 43,506 | 45,791 | 45,791 |
| End Cash Position | 114,103 | 85,789 | 73,065 | 43,506 | 45,913 |
| Net Cash Flow | $70,597 | $42,283 | $29,559 | $-2,285 | $122 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,358 | -58,293 | -30,626 | 26,451 | 46,358 |
| Capital Expenditure | -4,183 | -2,344 | -1,107 | -2,628 | -1,832 |
| Free Cash Flow | -86,541 | -60,637 | -31,733 | 23,823 | 44,526 |